Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells

References

• Acharya, S., Dilnawaz, F., and Sahoo, S.K., 2009. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials, 30, 5737–5750.
   PubMed Web of Science ®Google Scholar
• Adler, M.J. and Dimitrov, D.S., 2012. Therapeutic antibodies against cancer. Hematology/oncology clinics of North America, 26, 447–481.
   PubMed Web of Science ®Google Scholar
• Aramudan, S., 2016. Effects of pentapeptide conjugation on etoposide loaded polymeric micelles for the treatment of cancer cells. International journal of research in pharmaceutical sciences, 7, 132–141.
   Google Scholar
• Bhatt, P., et al., 2016. Anti-FSHR antibody Fab’ fragment conjugated immunoliposomes loaded with cyclodextrin-paclitaxel complex for improved in vitro efficacy on ovarian cancer cells. AACR.
   Google Scholar
• Blasi, P., et al., 2011. Lipid nanoparticles for brain targeting I. Formulation optimization. International journal of pharmaceutics, 419, 287–295.
   PubMed Web of Science ®Google Scholar
• Boven, E., et al., 1993. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer. Annals of oncology, 4, 321–324.
   PubMed Web of Science ®Google Scholar
• Canatella, P.J., et al., 2001. Quantitative study of electroporation-mediated molecular uptake and cell viability. Biophysical journal, 80, 755–764.
   PubMed Web of Science ®Google Scholar
• Cheng, J., et al., 2007. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 28, 869–876.
   PubMed Web of Science ®Google Scholar
• Clarke, S.J. and Rivory, L.P., 1999. Clinical pharmacokinetics of docetaxel. Clinical pharmacokinetics, 36, 99–114.
   PubMed Web of Science ®Google Scholar
• Ducat, E., et al., 2011. Cellular uptake of liposomes monitored by confocal microscopy and flow cytometry. Journal of drug delivery science and technology, 21, 469–477.
   Web of Science ®Google Scholar
• Elzoghby, A.O., Samy, W.M., and Elgindy, N.A., 2012. Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of controlled release, 157, 168–182.
   PubMed Web of Science ®Google Scholar
• Food & Administration, D., 2010. Draft guidance on doxorubicin hydrochloride.
   Google Scholar
• Green, M., Murray, J., and Hortobagyi, G., 2000. Monoclonal antibody therapy for solid tumors. Cancer treatment reviews, 26, 269–286.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2014. Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies. International journal of biological macromolecules, 69, 546–553.
   PubMed Web of Science ®Google Scholar
• Javia, A. and Thakkar, H., 2017. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation. Journal of microencapsulation, 34, 644–658.
   PubMed Web of Science ®Google Scholar
• Kang, B.K., et al., 2004. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. International journal of pharmaceutics, 286, 147–156.
   PubMed Web of Science ®Google Scholar
• Masood, F., 2016. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Materials science and engineering: C, 60, 569–578.
   PubMed Web of Science ®Google Scholar
• Maya, S., et al., 2014. Chitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cells. International journal of biological macromolecules, 69, 532–541.
   PubMed Web of Science ®Google Scholar
• Mo, Y. and Lim, L.Y., 2004. Mechanistic study of the uptake of wheat germ agglutinin‐conjugated PLGA nanoparticles by A549 cells. Journal of pharmaceutical sciences, 93, 20–28.
   PubMed Web of Science ®Google Scholar
• Mo, Y. and Lim, L.-Y., 2005. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. Journal of controlled release, 108, 244–262.
   PubMed Web of Science ®Google Scholar
• Ogawa, J.I., et al., 1993. Immunohistochemical study of glutathione‐related enzymes and proliferative antigens in lung cancer. Relation to cisplatin sensitivity. Cancer, 71, 2204–2209.
   PubMed Web of Science ®Google Scholar
• Ohsaki, Y., et al., 2000. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncology reports, 7, 603–608.
   PubMed Web of Science ®Google Scholar
• Otto, T. and Sicinski, P., 2017. Cell cycle proteins as promising targets in cancer therapy. Nature reviews cancer, 17, 93–115.
   PubMed Web of Science ®Google Scholar
• Pachauri, M., Gupta, E.D., and Ghosh, P.C., 2015. Piperine loaded PEG-PLGA nanoparticles: preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. Journal of drug delivery science and technology, 29, 269–282.
   Web of Science ®Google Scholar
• Perri, F., et al., 2012. 583 induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable head and neck cancer. Preliminary results of a phase I/II study. European journal of cancer, 48, 178–179.
   Web of Science ®Google Scholar
• Pirker, R., 2013. EGFR-directed monoclonal antibodies in non-small cell lung cancer. Targeted oncology, 8, 47–53.
   PubMed Web of Science ®Google Scholar
• Prabhu, R.H., Patravale, V.B., and Joshi, M.D., 2015. Polymeric nanoparticles for targeted treatment in oncology: current insights. International journal of nanomedicine, 10, 1001.
   PubMed Web of Science ®Google Scholar
• Rao, J.P. and Geckeler, K.E., 2011. Polymer nanoparticles: preparation techniques and size-control parameters. Progress in polymer science, 36, 887–913.
   Web of Science ®Google Scholar
• Scott, C.J., et al., 2008. Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles. Pharmaceutical research, 25, 135–146.
   PubMed Web of Science ®Google Scholar
• Shargh, V.H., Hondermarck, H., and Liang, M., 2016. Antibody-targeted biodegradable nanoparticles for cancer therapy. Nanomedicine, 11, 63–79.
   PubMed Web of Science ®Google Scholar
• Siegel, R.L., Miller, K.D., and Jemal, A., 2016. Cancer statistics, 2016. CA: a cancer journal for clinicians, 66, 7–30.
   PubMed Web of Science ®Google Scholar
• Sun, B., Ranganathan, B., and Feng, S.-S., 2008. Multifunctional poly(d, l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer. Biomaterials, 29, 475–486.
   PubMed Web of Science ®Google Scholar
• Weiss, G., et al., 2006. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer. Journal of clinical oncology, 24, 5477.
   Web of Science ®Google Scholar
• Win, K.Y. and Feng, S.-S., 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26, 2713–2722.
   PubMed Web of Science ®Google Scholar
• Wolpin, B.M., 2015. Pancreatic cancer: hematology/oncology clinics of North America. Philadelphia, PA: Elsevier Health Sciences.
   Google Scholar
• Yameen, B., et al., 2014. Insight into nanoparticle cellular uptake and intracellular targeting. Journal of controlled release, 190, 485–499.
   PubMed Web of Science ®Google Scholar
• Yuan, X., et al., 2015. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis. Scientific reports, 5, 10338.
   PubMed Web of Science ®Google Scholar
• Zarogoulidis, K., et al., 2013. Treatment of non-small cell lung cancer (NSCLC). Journal of thoracic disease, 5, S389–S396.
   PubMed Web of Science ®Google Scholar
• Zhao, H. and Yung, L.Y.L., 2008. Selectivity of folate conjugated polymer micelles against different tumor cells. International journal of pharmaceutics, 349, 256–268.
   PubMed Web of Science ®Google Scholar
• Zhao, P. and Astruc, D., 2012. Docetaxel nanotechnology in anticancer therapy. ChemMedChem, 7, 952–972.
   PubMed Web of Science ®Google Scholar